These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 29315755)
21. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
22. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway. Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma. Li Y; Xu D; Bao C; Zhang Y; Chen D; Zhao F; Ding J; Liang L; Wang Q; Liu L; Li J; Yao M; Huang S; He X Oncotarget; 2015 Feb; 6(4):2421-33. PubMed ID: 25537516 [TBL] [Abstract][Full Text] [Related]
24. HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis. Chen SL; Liu LL; Lu SX; Luo RZ; Wang CH; Wang H; Cai SH; Yang X; Xie D; Zhang CZ; Yun JP Mol Oncol; 2017 Sep; 11(9):1225-1240. PubMed ID: 28580773 [TBL] [Abstract][Full Text] [Related]
25. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
26. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012 [TBL] [Abstract][Full Text] [Related]
27. EGF promotes Niu J; Li W; Liang C; Wang X; Yao X; Yang RH; Zhang ZS; Liu HF; Liu FY; Pei SH; Li WQ; Sun H; Fang D; Xie SQ Sci Signal; 2020 Nov; 13(657):. PubMed ID: 33172955 [TBL] [Abstract][Full Text] [Related]
28. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181 [TBL] [Abstract][Full Text] [Related]
29. [Expression of integrin alpha 5, beta 1 subunit and fibronectin mRNAs in human hepatocellular carcinoma]. Zhao J; Zhai W; Zhang Y Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):94-8. PubMed ID: 11244970 [TBL] [Abstract][Full Text] [Related]
30. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma. Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627 [TBL] [Abstract][Full Text] [Related]
31. Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor. D'Alessandro R; Refolo MG; Lippolis C; Carella N; Messa C; Cavallini A; Carr BI Cancer Chemother Pharmacol; 2015 Jun; 75(6):1237-1245. PubMed ID: 25907508 [TBL] [Abstract][Full Text] [Related]
32. DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling. Dong L; Li Z; Xue L; Li G; Zhang C; Cai Z; Li H; Guo R Mol Cell Biochem; 2018 Jan; 438(1-2):183-190. PubMed ID: 28795316 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway. Geng D; Zhao W; Feng Y; Liu J Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539 [TBL] [Abstract][Full Text] [Related]
34. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034 [TBL] [Abstract][Full Text] [Related]
35. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression. Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
37. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling. Yang G; Liang Y; Zheng T; Song R; Wang J; Shi H; Sun B; Xie C; Li Y; Han J; Pan S; Lan Y; Liu X; Zhu M; Wang Y; Liu L Cancer Lett; 2016 Aug; 378(2):80-6. PubMed ID: 27177473 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway. Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712 [TBL] [Abstract][Full Text] [Related]
39. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Zhang J; Zhang DL; Jiao XL; Dong Q Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232 [TBL] [Abstract][Full Text] [Related]
40. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform. Li J; You S; Zhang S; Hu Q; Wang F; Chi X; Zhao W; Xie C; Zhang C; Yu Y; Liu J; Zhao Y; Liu P; Zhang Y; Wei X; Li Q; Wang X; Yin Z Mol Oncol; 2019 Sep; 13(9):1993-2009. PubMed ID: 31294922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]